{"id":"W2791839805","doi":"10.1111/jdv.14910","title":"Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized <scp>VOYAGE</scp> 1 trial","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Adalimumab; Psoriasis; Placebo; Randomized controlled trial; Internal medicine; Surgery; Dermatology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003723465,0.001110433,0.002829197,0.0003079573,0.0003434447,0.001137454,0.0007914968,0.001707835,0.004892932],"category_scores_gemma":[0.003314344,0.0004709128,0.003006455,0.0003416981,0.0008748865,0.0007956321,0.0003463878,0.002556149,0.0006145785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005797598,"about_ca_system_score_gemma":0.0007962692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006290106,"about_ca_topic_score_gemma":0.001268452,"domain_scores_codex":[0.9982174,0.001190815,0.00010822,0.0001874998,0.0001416109,0.0001544653],"domain_scores_gemma":[0.998097,0.0007376234,0.0005482496,0.0001514925,0.00009977199,0.0003657714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9795215,0.002209027,0.001415299,0.0006290516,0.001753859,0.000019413,0.00004225156,0.0001785627,0.0009209389,0.00005602154,0.001007375,0.0122467],"study_design_scores_gemma":[0.9653431,0.02617283,0.005750292,0.00008564755,0.001458865,0.00005054339,0.00002374773,0.0002185473,0.0001959081,0.0001331391,0.000553922,0.00001349687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826701,0.01127518,0.0003910763,0.0007561417,0.0003701715,0.001031467,0.001311128,0.0000717935,0.002122864],"genre_scores_gemma":[0.990186,0.003893125,0.0005253205,0.0009050655,0.0003854357,0.001219589,0.001629883,0.00002056905,0.001235129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004892932,"threshold_uncertainty_score":0.01969177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02193684542819177,"score_gpt":0.2407754879448709,"score_spread":0.2188386425166791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}